REGIME DE DOSAGEM PARA UM AGONISTA DE RECETOR DE S1P
- 专利权人:
- NOVARTIS AG
- 发明人:
- ROBERT SCHMOUDER,THOMAS DUMORTIER,OLIVIER DAVID,MICHAEL LOOBY
- 申请号：
- PT18179301
- 公开号：
- PT3409274T
- 申请日:
- 2009.12.21
- 申请国别(地区):
- PT
- 年份:
- 2019
- 代理人:
- 摘要：
- S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- usos de um composto e de um modulador, e, composto
- Dosing regimen for treating solid tumours
- METHODS FOR TREATING A TUMOR, FOR TREATING A PATHOLOGICAL CONDITION ASSOCIATED WITH ANGIOGENESIS, TO STIMULATING ENDOTHELIAL CELL PROLIFERATION, TO REDUCE OR INHIBIT ENDOTHELIAL CELL DIFFERENTIATION, TO REDUCE OR INHIBIT TO DEVELOP, DETERMINING, DETECTING EFFECTIVENESS OF AN ANTI-ANGIOGENIC AGENT, USES OF A DLL4 ANTAGONIST AND USE OF A DLL4 AGONISTER
- REGIME POSOLOGIQUE D'UN AGONISTE DU RECEPTEUR S1P
- TREATMENT METHOD OF A HUMAN GUY.
